Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®): A Review of Its Use in the Prevention of Premalignant Anogenital …

PL McCormack - Drugs, 2014 - Springer
Quadrivalent human papillomavirus (HPV)[types 6, 11, 16, 18] recombinant vaccine
(Gardasil®; Silgard®) is composed of virus-like particles formed by self-assembly of …

Human Papilloma Virus Vaccines

M Stanley - Medicines For Women, 2014 - Springer
Benign and malignant disease caused by HPV (human papillomavirus) constitutes a global
public health problem. Genital warts are the commonest viral sexually transmitted infection …

Adolescent premature ovarian insufficiency following human papillomavirus vaccination: a case series seen in general practice

DT Little, HRG Ward - Journal of investigative medicine high …, 2014 - journals.sagepub.com
Three young women who developed premature ovarian insufficiency following quadrivalent
human papillomavirus (HPV) vaccination presented to a general practitioner in rural New …

[PDF][PDF] Vacunas frente al virus del papiloma humano

L Bruni, X Castellsagué, FX Bosch - Vacunas, 2014 - academia.edu
Esta revisión se centra en publicaciones de los ensayos clínicos de fase II y III llevados a
cabo con dos vacunas profilácticas frente al VPH: Gardasil®(Merck & Co., Inc., Whitehouse …

Malattie autoimmuni e vaccinazioni

C Betterle, G Zanoni - L'Endocrinologo, 2014 - Springer
La medicina fonda le sue radici sulla prevenzione e la cura delle malattie umane. In quanto
tale, essa deve aspirare a prevenire e curare la maggior parte degli individui. Essa è …